Editing the Human Genome
By BBC Newshour Extra,
BBC Newshour Extra
| 11. 28. 2015
Remarkable new techniques for ‘editing’ DNA – chemically cutting and splicing sections of genetic code – are revolutionising research in laboratories around the world. The potential for eradicating hereditary diseases is enormous. But are the benefits outweighed by the risks involved? And should these techniques ever be used on humans? On Newshour Extra this week, Owen Bennett Jones and his panel of expert guests discuss the scientific and ethical consequences of this latest research, and ask whether mankind should be tinkering with our genetic inheritance.
Contributors: Prof Robin Lovell-Badge - Head of Stem Cell Biology and Developmental Genetics at the Francis Crick Institute; Michael Le Page -New Scientist magazine; Dr Annelien Bredenoord - Associate Professor of Biomedical Ethics at the University Medical Centre in Utrecht; Marcy Darnovsky - Executive Director of the Center for Genetics and Society, Berkeley, California; James Rushbrooke - playwrite; Edward Perello - co-founder of Desktop Genetics
Related Articles
By Mike McIntire, The New York Times | 01.24.2026
Genetic researchers were seeking children for an ambitious, federally funded project to track brain development — a study that they told families could yield invaluable discoveries about DNA’s impact on behavior and disease.
They also promised that the children’s sensitive...
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...